Copyright
©The Author(s) 2021.
World J Hepatol. Dec 27, 2021; 13(12): 2071-2080
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2071
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2071
Table 1 Patients’ demographics and clinical characteristics
Control group (n = 17) | Liver cirrhosis | P value | ||
Pugh-Child A + B (n = 37) | Pugh-Child C (n = 32) | |||
Age (yr) | 43.7 ± 14.6 | 55.7 ± 12.1 | 55.9 ± 10.2 | 0.021 |
Percentage of males (%) | 64.3% | 73% | 72.7% | 0.52 |
Body weight (kg) | 67.6 ± 8.9 | 73 ± 11.4 | 75.5 ± 12.8 | 0.17 |
Height (cm) | 173 ± 5.9 | 174 ± 8 | 173 ± 7.6 | 0.64 |
Duration of alcohol abuse (yr) | - | 15.7 ± 8.2 | 18.7 ± 8.3 | 0.98 |
Oesophageal varices (%) | - | 32.4% | 81.8% | < 0.0001 |
Encephalopathy (%) | - | 32.4% | 83.9% | < 0.0001 |
Ascites (%) | - | 40.5% | 90.9% | < 0.0001 |
Total bilirubin (mg/dL) | 0.6 ± 0.3 | 4.6 ± 6.9 | 10.5 ± 9.2 | < 0.0001 |
INR | - | 1.36 ± 0.35 | 1.95 ± 0.56 | < 0.0001 |
Albumin (g/dL) | - | 3.1±0.8 | 2.4±0.4 | 0.0002 |
Total protein (g/dL) | 6.3 ± 0.3 | 6.4 ± 1 | 5.9 ± 0.9 | 0.16 |
Alanine aminotransferase (U/L) | 17.9 ± 6 | 65.3 ± 139.9 | 50.6 ± 87.3 | 0.018 |
Aspartate aminotransferase (U/l) | 18.3 ± 7 | 128.1 ± 173.5 | 120 ± 164.7 | < 0.0001 |
Platelets (G/L) | 231.4 ± 29.8 | 173 ± 105.4 | 127.8 ± 72.3 | 0.0004 |
Mean corpuscular volume (fL) | 84.8 ± 3.5 | 91.2 ± 9.1 | 95.5 ± 9 | 0.0002 |
Urea (mg/dL) | - | 27.5 ± 16.1 | 58.2 ± 43.7 | 0.065 |
Sodium (mmol/l) | 140 ± 3.3 | 133.8 ± 5 | 131.9 ± 6.7 | < 0.0001 |
Potassium (mmol/L) | 4.4 ± 0.4 | 3.8 ± 0.7 | 3.9 ± 0.8 | 0.019 |
C-reactive protein (mg/L) | 2.5 ± 2.3 | 19.8 ± 21 | 32.7 ± 27.8 | < 0.0001 |
Angiotensinogen (ng/mL) | 1006.91 ± 610.49 | 1117.04 ± 873.69 | 1468.7 ± 817.33 | 0.22 |
Table 2 Levels of selected biochemical parameters according to the stage of liver cirrhosis
Control group | Liver cirrhosis | P value | ||
Pugh-Child A + B | Pugh-Child C | |||
LECT2 (ng/mL) | 18.99 ± 5.36 | 11.06 ± 6.47 | 8.06 ± 5.74 | < 0.0001 |
FGF-1 (pg/mL) | 37.94 ± 40.4 | 144.77 ± 14.42 | 164.52 ± 169.46 | 0.01 |
FGF-21 (pg/mL) | 13.52 ± 7.51 | 44.27 ± 64.19 | 45.4 ± 51.69 | 0.008 |
Table 3 Correlations between leukocyte cell-derived chemotaxin-2 and other clinical and laboratory parameters (only those statistically significant were included)
Pair of variables | Correlation coefficient | ||
R | P value | ||
LECT2 | Age | -0.29 | 0.048 |
Total bilirubin | -0.59 | < 0.0001 | |
Platelets | 0.34 | 0.02 | |
Alanine transaminase | -0.43 | 0.003 | |
C-reactive protein | -0.4 | 0.008 | |
Angiotensinogen | -0.51 | < 0.0001 | |
FGF-1 | -0.38 | 0.004 | |
FGF-21 | -0.39 | 0.004 |
Table 4 Independent factors associated with leukocyte cell-derived chemotaxin-2 concentration (multiple regression)
Effect | B* | SE with B* | B | SE with B | P value |
Constant | 30.64 | 3.68 | < 0.0001 | ||
Angiotensinogen | -0.423 | 0.114 | -0.004 | 0.001 | 0.001 |
Alanine aminotransferase | -0.341 | 0.115 | -0.02 | 0.005 | 0.005 |
Total bilirubin | -0.279 | 0.108 | -0.25 | 0.099 | 0.014 |
Age | -0.275 | 0.109 | -0.16 | 0.064 | 0.016 |
- Citation: Sak JJ, Prystupa A, Kiciński P, Luchowska-Kocot D, Kurys-Denis E, Bis-Wencel H. Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis. World J Hepatol 2021; 13(12): 2071-2080
- URL: https://www.wjgnet.com/1948-5182/full/v13/i12/2071.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i12.2071